Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
nadroparin (1 trial)
sodium chloride (1 trial)
Thromboembolism (Phase 3)
Trials (1 total)
Trial APIs (2 total)